Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 246
Filter
1.
Int J Mol Sci ; 22(5)2021 Mar 04.
Article in English | MEDLINE | ID: mdl-33806352

ABSTRACT

Lipids play essential roles in numerous cellular processes, including membrane remodeling, signal transduction, the modulation of hormone activity, and steroidogenesis. We chose steroidogenic MA-10 mouse tumor Leydig cells to investigate subcellular lipid localization during steroidogenesis. Electron microscopy showed that cAMP stimulation increased associations between the plasma membrane (PM) and the endoplasmic reticulum (ER) and between the ER and mitochondria. cAMP stimulation also increased the movement of cholesterol from the PM compared to untreated cells, which was partially inhibited when ATPase family AAA-domain containing protein 3 A (ATAD3A), which functions in ER and mitochondria interactions, was knocked down. Mitochondria, ER, cytoplasm, PM, PM-associated membranes (PAMs), and mitochondria-associated membranes (MAMs) were isolated from control and hormone-stimulated cells. Lipidomic analyses revealed that each isolated compartment had a unique lipid composition, and the induction of steroidogenesis caused the significant remodeling of its lipidome. cAMP-induced changes in lipid composition included an increase in phosphatidylserine and cardiolipin levels in PAM and PM compartments, respectively; an increase in phosphatidylinositol in the ER, mitochondria, and MAMs; and a reorganization of phosphatidic acid, cholesterol ester, ceramide, and phosphatidylethanolamine. Abundant lipids, such as phosphatidylcholine, were not affected by hormone treatment. Our data suggested that PM-ER-mitochondria tethering may be involved in lipid trafficking between organelles and indicated that hormone-induced acute steroid production involves extensive organelle remodeling.


Subject(s)
Leydig Cell Tumor/metabolism , Membrane Lipids/metabolism , Steroids/biosynthesis , Testicular Neoplasms/metabolism , ATPases Associated with Diverse Cellular Activities/antagonists & inhibitors , ATPases Associated with Diverse Cellular Activities/genetics , ATPases Associated with Diverse Cellular Activities/metabolism , Animals , Bucladesine/pharmacology , Cell Line, Tumor , Cell Membrane/metabolism , Cholesterol/metabolism , Cyclic AMP/pharmacology , Endoplasmic Reticulum/metabolism , Gene Knockdown Techniques , Leydig Cell Tumor/ultrastructure , Lipidomics , Male , Mice , Microscopy, Electron, Transmission , Mitochondrial Membranes/metabolism , Mitochondrial Proteins/antagonists & inhibitors , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Models, Biological , Testicular Neoplasms/ultrastructure
2.
Oxid Med Cell Longev ; 2021: 8026941, 2021.
Article in English | MEDLINE | ID: mdl-33603952

ABSTRACT

DLBCL is the most common type of non-Hodgkin lymphoma with a substantial group of patients suffering a poor prognosis. Therefore more specific markers are required for better understanding of disease biology and treatment. This study demonstrates that testis-specific antioxidant enzymes TXNDC2, TXNDC3, and TXNDC6 alongside oxidative stress marker 8-OHdG are expressed in both testicular and systemic DLBCL, and their presence or absence has correlations with clinical risk factors such as the number of extranodal effusion, the appearance of B-symptoms, and treatment response. Biopsy samples were collected from 28 systemic and 21 testicular male DLBCL patients. The samples were histostained with TXNDC2, TXNDC3, TXNDC6, and 8-OHdG, then graded by a hematopathologist blinded to clinical data. Immunoelectron microscopy was used as a second method to confirm the reliability of the acquired immunohistochemistry data. The absence of nuclear TXNDC2 expression in testicular DLBCL cells correlated with worse primary treatment response, cytoplasmic TXNDC3 expression in testicular and systemic DLBCL associated with lower frequency of B-symptoms, and TXNDC6 expression in cytoplasm in systemic DLBCL had a clinical significance with higher LD levels suggesting a role in the biological nature of these lymphomas. Overall, TXNDC3 cytoplasmic expression is correlated with a more positive outcome in both testicular and systemic DLBCL, while TXNDC6 cytoplasmic expression is associated with a negative outcome in systemic DLBCL.


Subject(s)
Lymphoma, Large B-Cell, Diffuse/metabolism , Lymphoma, Large B-Cell, Diffuse/pathology , Membrane Proteins/metabolism , Testicular Neoplasms/metabolism , Testicular Neoplasms/pathology , Testis/metabolism , Thioredoxins/metabolism , 8-Hydroxy-2'-Deoxyguanosine/metabolism , Cell Line, Tumor , Humans , Lymphoma, Large B-Cell, Diffuse/ultrastructure , Male , Middle Aged , Organ Specificity , Testicular Neoplasms/ultrastructure , Testis/pathology , Testis/ultrastructure
3.
Medicine (Baltimore) ; 97(22): e10736, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29851778

ABSTRACT

RATIONALE: Cutaneous metastasis of testicular choriocarcinoma is exceptionally uncommon. To our knowledge, only 14 cases have been reported in the past 10 years in the pubmed. We have an uncommon case of testicular choriocarcinoma who has metastasized to the adjacent skin and organ systems. PATIENT CONCERNS: An 18-year-old male was diagnosed with initial presentation of cutaneous mass at the left back. Followly,biopsy was performed under local anesthesia.Histopathological examination was consistent with the diagnosis of metastatic choriocarcinoma. DIAGNOSES: The histopathological assessment of the biopsied tissue, in combination with elevated serum ß-HCG levels and presentation of testicular mass, indicated primary testicular choriocarcinoma with cutaneous and systemic metastasis. INTERVENTIONS: Subsequently radical orchiectomy was performed. OUTCOMES: Despite the case completed one cycle of cisplatin-based regimen chemotherapy, he died of multiple organ dysfunction syndrome 2 months after surgery. LESSONS: In this report, cutaneous metastasis with testicular choriocarcinoma is extremely rare. It is important to recognize that this unusual variant of testicular choriocarcinoma has the potential to behave aggressively and to metastasize.


Subject(s)
Choriocarcinoma/pathology , Skin Neoplasms/pathology , Skin Neoplasms/secondary , Skin/pathology , Abdomen/diagnostic imaging , Abdomen/pathology , Adolescent , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Choriocarcinoma/blood , Choriocarcinoma/drug therapy , Choriocarcinoma/surgery , Chorionic Gonadotropin, beta Subunit, Human/blood , Cisplatin/therapeutic use , Fatal Outcome , Humans , Male , Multiple Organ Failure/complications , Orchiectomy/methods , Testicular Neoplasms/drug therapy , Testicular Neoplasms/pathology , Testicular Neoplasms/surgery , Testicular Neoplasms/ultrastructure , Thorax/diagnostic imaging , Thorax/pathology , Tomography, X-Ray Computed
5.
J Cell Biochem ; 117(4): 1027-32, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26515240

ABSTRACT

The cellular basis of metastasis is poorly understood. An important step to understanding this process is to be able to visualize the routes by which cancer cells migrate from the primary tumor to various distant sites to eventually form metastasis. Our laboratory previously developed single-cell in vivo imaging using fluorescent proteins to label cancer cells. In the present study, using PC-3 human prostate cancer cells labeled with green fluorescent protein (GFP) and orthotopic tumor transplantation, we have imaged in live mice various highly diverse routes by which PC-3 cells metastasize superiorly and inferiorly to distant sites, including in the portal area, stomach area, and urogenital system. Imaging began at day 9, at which time distant metastasis had already occurred, and increased at each imaging point at days 10, 13, 14, and 16. Metastatic cells were observed migrating superiorly and inferiorly from the primary tumor as well as in lymphatic channels and trafficking in various organ systems demonstrating that PC-3 has multiple metastatic routes similar to hormone-independent advanced-stage prostate cancer in the clinic.


Subject(s)
Cell Tracking/methods , Diagnostic Imaging/methods , Pancreatic Neoplasms/diagnosis , Prostatic Neoplasms/diagnosis , Stomach Neoplasms/diagnosis , Testicular Neoplasms/diagnosis , Urinary Bladder Neoplasms/diagnosis , Animals , Cell Line, Tumor , Cell Movement , Gene Expression , Genes, Reporter , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Lymphatic Metastasis , Male , Mice , Mice, Nude , Mice, Transgenic , Neoplasm Invasiveness , Neoplasm Transplantation , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/secondary , Pancreatic Neoplasms/ultrastructure , Prostate/metabolism , Prostate/pathology , Prostate/ultrastructure , Prostatic Neoplasms/genetics , Prostatic Neoplasms/pathology , Prostatic Neoplasms/ultrastructure , Stomach Neoplasms/genetics , Stomach Neoplasms/secondary , Stomach Neoplasms/ultrastructure , Testicular Neoplasms/genetics , Testicular Neoplasms/secondary , Testicular Neoplasms/ultrastructure , Transplantation, Heterologous , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/secondary , Urinary Bladder Neoplasms/ultrastructure
7.
Ultrastruct Pathol ; 37(5): 373-7, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24047353

ABSTRACT

Infertility is sometimes more a man's problem than a woman's, failure of one or both of the testes to descend (cryptorchidism) being the most frequent genital malformation in boys. Untreated, the undescended testis impairs germ cell development and significantly reduces adult fertility. A-dark spermatogonia are the stem cells for all future spermatozoa, and their depletion can be reliably estimated in resin semithin sections. Additionally, there is an increased risk of testicular preneoplasia in the form of carcinoma in situ (CIS) cells. The authors report how the pathologic biopsy examination of juvenile cryptorchid testes can assess infertility and malignancy risk.


Subject(s)
Carcinoma in Situ/etiology , Cryptorchidism/complications , Epoxy Resins , Infertility, Male/etiology , Neoplasms, Germ Cell and Embryonal/etiology , Spermatogonia/ultrastructure , Testicular Neoplasms/etiology , Testis/ultrastructure , Age Factors , Biopsy , Carcinoma in Situ/ultrastructure , Case-Control Studies , Child , Child, Preschool , Cryptorchidism/pathology , Humans , Infertility, Male/pathology , Male , Microscopy, Electron , Neoplasms, Germ Cell and Embryonal/ultrastructure , Risk Factors , Testicular Neoplasms/ultrastructure
9.
J Transl Med ; 10: 46, 2012 Mar 13.
Article in English | MEDLINE | ID: mdl-22410253

ABSTRACT

The testicular yolk sac tumor (TYST) is the most common neoplasm originated from germ cells differentiated abnormally, a major part of pediatric malignant testicular tumors. The present study aimed at developing and validating the in vitro and vivo models of TYST and evaluating the sensitivity of TYST to treatments, by cloning human TYST cells and investigating the histology, ultra-structure, growth kinetics and expression of specific proteins of cloned cells. We found biological characteristics of cloned TYST cells were similar to the yolk sac tumor and differentiated from the columnar to glandular-like or goblet cells-like cells. Chromosomes for tumor identification in each passage met nature of the primary tumor. TYST cells were more sensitive to all-trans-retinoic acid which had significantly inhibitory effects on cell proliferation. Cisplatin induced apoptosis of TYST cells through the activation of p53 expression and down-regulation of Bcl- expression. Thus, we believe that cloned TYST cells and the animal model developed here are useful to understand the molecular mechanism of TYST cells and develop potential therapies for human TYST.


Subject(s)
Endodermal Sinus Tumor/drug therapy , Testicular Neoplasms/drug therapy , Tretinoin/therapeutic use , Xenograft Model Antitumor Assays , Animals , Cell Cycle/drug effects , Cell Proliferation/drug effects , Child, Preschool , Cisplatin/pharmacology , Clone Cells , Endodermal Sinus Tumor/pathology , Endodermal Sinus Tumor/ultrastructure , Humans , Male , Mice , Mice, Inbred BALB C , Neoplasm Proteins/metabolism , Testicular Neoplasms/pathology , Testicular Neoplasms/ultrastructure , Tretinoin/pharmacology , Tumor Burden/drug effects , alpha-Fetoproteins/metabolism
10.
Toxicol Ind Health ; 26(8): 451-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20504820

ABSTRACT

The morphological consequences of chronic exposition to low doses of cadmium (Cd) in the Leydig cells population were investigated in 40 sexually mature male mice at morphological and ultrastructural levels. Animals were orally exposed to cadmium (0.015 g/L of CdCl(2) in drinking water) for 3, 6, 12 and 18 months and then sacrificed, samples were collected for toxicological, light and electron microscope studies. Vascular lesions were evident from 6 months of Cd exposure, the severity of the morphological changes observed in the testicular vases were highly and clearly correlated to the time of exposure to Cd. The severity of the Leydig cells morphological changes were increasing along the time of exposure. Presence of cytoplasm vacuolization and degenerative images of the cells were frequent after 12 months of Cd exposure. Also two Leydig cells tumours after 12 and 18 months Cd exposure were presented. These results indicate that prolonged exposures to low doses of Cd are able to induce morphological damage on the Leydig cells.


Subject(s)
Cadmium/toxicity , Carcinogens/toxicity , Leydig Cell Tumor/pathology , Leydig Cells/drug effects , Precancerous Conditions/pathology , Testicular Neoplasms/pathology , Animals , Carcinogenicity Tests , Dose-Response Relationship, Drug , Leydig Cell Tumor/ultrastructure , Leydig Cells/pathology , Leydig Cells/ultrastructure , Male , Mice , Precancerous Conditions/ultrastructure , Testicular Neoplasms/ultrastructure
11.
Pathol Oncol Res ; 16(2): 177-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19731088

ABSTRACT

Primary testicular leiomyosarcoma is an uncommon tumor with only few cases described in literature. In young people this rare tumor seems to be related to radiotherapy and anabolic steroids abuse. In older people there are apparently no risk factors. We describe one further case in a 77-years old man with full histological and ultrastructural evaluation. A short term follow-up of one year signals no recurrence of the disease.


Subject(s)
Leiomyosarcoma/ultrastructure , Testicular Neoplasms/ultrastructure , Aged , Humans , Leiomyosarcoma/metabolism , Leiomyosarcoma/surgery , Male , Orchiectomy , Testicular Neoplasms/metabolism , Testicular Neoplasms/surgery
12.
Hum Pathol ; 41(4): 552-9, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20004940

ABSTRACT

Four cases of large cell calcifying Sertoli cell tumor, 3 benign and 1 malignant, with no clinical signs of Carney complex or Peutz-Jeghers syndrome are reported with results of histologic, immunohistochemical, ultrastructural, and comparative genomic hybridization studies. Analysis of PRKAR1A gene was performed on 2 cases. The age range of the patients was 19 to 54 years. The patient with a malignant large cell calcifying Sertoli cell tumor died of disease 4 years after surgery. Patients with benign tumors have had an uneventful follow-up for 1 and 3 years. All tumors were well circumscribed, unencapsulated, and composed of solid sheets, irregular cords, tubular structures, and nests in a fibrous and/or myxoid stroma with cellular atypia in the malignant case. All tumors showed diffuse immunoreactivity for inhibin, vimentin, calretinin, and S100 protein. Focal positivity for cytokeratin (AE1/AE3) was noticed in 1 case. Tumors were negative for CAM 5.2, Mic-2, Melan-A laminin, placental alkaline phosphatase, and alpha-fetoprotein. The proliferation index was 5% and 10% for 2 of the benign tumors and 30% for the malignant tumor. Comparative genomic hybridization was performed in 2 cases. There was no evidence of any major chromosomal changes. In one case, no PRKAR1A gene mutation was found. In the other case, a heterozygous shift mutation c.65_84dup was found, despite the absence of other clinical signs of Carney complex or Peutz-Jeghers syndrome. Although the combination of large cell calcifying Sertoli cell tumor and PRKAR1A mutation fulfills the criteria for establishing a diagnosis of Carney complex, the clinical relevance of finding a PRKAR1A gene mutation in a patient without any clinical signs of Carney complex or Peutz-Jeghers syndrome remains to be established.


Subject(s)
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit/metabolism , Sertoli Cell Tumor/metabolism , Testicular Neoplasms/metabolism , Adult , Calcinosis/metabolism , Calcinosis/pathology , Comparative Genomic Hybridization , Cyclic AMP-Dependent Protein Kinase RIalpha Subunit/genetics , Humans , Immunohistochemistry , Male , Middle Aged , Mutation , Polymerase Chain Reaction , Sertoli Cell Tumor/pathology , Sertoli Cell Tumor/ultrastructure , Testicular Neoplasms/pathology , Testicular Neoplasms/ultrastructure , Young Adult
13.
Histochem Cell Biol ; 131(6): 755-64, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19241088

ABSTRACT

In mouse testis, claudin-11 is responsible for the formation of specific parallel TJ strands of the blood-testis barrier (BTB). Concerning the human BTB, there is no information about the transmembrane TJ proteins. We recently demonstrated the loss of functional integrity of the BTB in testicular intraepithelial neoplasia (TIN), associated with a dislocation of the peripheral TJ proteins ZO-1 and ZO-2. Here, we determined the expression and distribution of claudin-11 at the human BTB in seminiferous tubules with normal spermatogenesis (NSP) and TIN. Immunostaining of claudin-11 revealed intense signals at the basal BTB region in seminiferous epithelium with NSP. Within TIN tubules, claudin-11 immunostaining became diffuse and cytoplasmic. Double immunogold labeling demonstrated a co-localization of claudin-11 and ZO-1 at the inter-Sertoli cell junctions. Real-time RT-PCR of laser microdissected tubules showed an up-regulation of claudin-11 mRNA in TIN. Additionally, increased claudin-11 protein was observed by Western blot. We conclude that claudin-11 constitutes a TJ protein at the human BTB. In TIN tubules, claudin-11 is up-regulated and dislocated from the BTB. Therefore, the disruption of the BTB is related to a dysfunction of claudin-11 and not to a failure of its expression.


Subject(s)
Blood-Testis Barrier/metabolism , Nerve Tissue Proteins/metabolism , Seminiferous Epithelium/metabolism , Seminiferous Tubules/metabolism , Sertoli Cells/metabolism , Adult , Blood-Testis Barrier/cytology , Claudins , Humans , Male , Membrane Proteins/metabolism , Microscopy, Immunoelectron , Middle Aged , Phosphoproteins/metabolism , Seminiferous Epithelium/cytology , Seminiferous Epithelium/ultrastructure , Seminiferous Tubules/cytology , Seminiferous Tubules/ultrastructure , Sertoli Cells/cytology , Spermatogenesis/physiology , Testicular Neoplasms/metabolism , Testicular Neoplasms/ultrastructure , Testis/cytology , Testis/metabolism , Testis/ultrastructure , Up-Regulation , Zonula Occludens-1 Protein
14.
Jpn J Clin Oncol ; 39(2): 124-6, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19066212

ABSTRACT

With the extensive use of scrotal ultrasound (US), incidental non-palpable testicular tumors have thus been unexpectedly discovered. This report documents the case of 24-year-old male with a non-palpable testicular tumor that contained non-seminomatous germ cell components detected by US. Radical orchiectomy was performed and histological examinations confirmed a diagnosis of a mixed tumor of seminoma and embryonal carcinoma. Serum alpha-fetoprotein (AFP) rose from 7.8 to 43 ng/ml and CT scan revealed multiple metastases only 1 month after the operation. Systemic chemotherapy was introduced immediately, and the serum level of AFP decreased to the normal range and the metastatic lesions had disappeared after three courses of the chemotherapy. No recurrence was observed at 18 months follow-up after the chemotherapy. This is the first case of non-palpable testicular embryonal carcinoma, which metastasized soon after the resection. The obscurity and implications of such a diagnosis are also discussed.


Subject(s)
Carcinoma, Embryonal/diagnostic imaging , Testicular Neoplasms/ultrastructure , Carcinoma, Embryonal/pathology , Humans , Male , Neoplasm Metastasis , Testicular Neoplasms/pathology , Ultrasonography , Young Adult
15.
Virchows Arch ; 453(2): 189-96, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18425535

ABSTRACT

The nuage, an ultrastructural marker of normal human germ cells (spermatogonia type A and primary spermatocytes), may be found associated with mitochondria (intermitochondrial cement) and/or free in the cytoplasm. Eight specimens from germ cell-related tumours were reviewed to assess whether the nuage could have diagnostic significance in testicular neoplasms. The nuage of neoplastic cells from seven classical seminomas and one spermatocytic seminoma was compared with that from two normal testes. The ultrastructural study demonstrated that only spermatocytic seminoma cells contained both types of nuage and that significantly fewer spermatocytic seminoma cells (28%) contained intermitochondrial cement compared with control spermatogonia type A (81.1%) and primary spermatocytes (47.6%). The data indicate that (1) the detection of the nuage confirms that the phenotype of spermatocytic seminoma is more differentiated than that of classical seminoma; (2) the intermitochondrial cement is an additional example of how a distinctive organelle of a normal cell is preserved in its neoplastic counterpart and (3) if the intermitochondrial cement were found in other cases of spermatocytic seminoma, this organelle of the normal germ cell lineage could be considered as a new ultrastructural marker of the neoplasm.


Subject(s)
Mitochondria/ultrastructure , Seminoma/ultrastructure , Spermatocytes/ultrastructure , Testicular Neoplasms/ultrastructure , Testis/ultrastructure , Adult , Humans , Immunohistochemistry , Male , Middle Aged
16.
Ultrastruct Pathol ; 31(1): 63-71, 2007.
Article in English | MEDLINE | ID: mdl-17455099

ABSTRACT

Penile malignancies are rare in developed countries. The authors present a case of a penile urethral mesenchymal tumor occurring in a 51-year-old Caucasian male and displaying light microscopic, immunohistochemical, and ultrastructural features suggestive of a pacemaker cell type, combined with a lack of diagnostic features of any other established tumor category. The immunohistochemical profile was intensely positive for vimentin, PKC theta, and NSE and weakly positive to nonreactive for CD34 and smooth muscle actin, and entirely negative for CD117 (c-kit), S-100, and other markers. C-kit and PDGFRA gene analysis showed no mutations. Electron microscopy revealed tumor cells with plentiful cytoplasm and cytoplasmic processes/filopodia, both filled with intermediate filaments and occasional solitary focal densities. There were also prominent smooth endoplasmic reticulum cisternae, caveolae, neurosecretory granules, particularly concentrated in cytoplasmic processes, and synaptic-type structures. Poorly formed basal lamina, gap junctions, and intercellular collagen aggregates, consistent with skeinoid-type fibers, were also noted. Interstitial cells with potential pacemaker function have been recently described in the lower urinary tract, including the urethra, and this tumor may be related to this cellular phenotype.


Subject(s)
Leydig Cell Tumor/ultrastructure , Testicular Neoplasms/ultrastructure , Urethral Neoplasms/ultrastructure , Actins/analysis , Antigens, CD34/analysis , DNA Mutational Analysis , Humans , Immunohistochemistry , Isoenzymes/analysis , Leydig Cell Tumor/chemistry , Leydig Cell Tumor/genetics , Male , Microscopy, Electron , Middle Aged , Phenotype , Protein Kinase C/analysis , Protein Kinase C-theta , Stromal Cells/ultrastructure , Testicular Neoplasms/chemistry , Testicular Neoplasms/genetics , Urethral Neoplasms/chemistry , Urethral Neoplasms/genetics , Vimentin/analysis
17.
Ultrastruct Pathol ; 30(1): 37-51, 2006.
Article in English | MEDLINE | ID: mdl-16517469

ABSTRACT

Mesothelial proliferations, either reactive or neoplastic in nature, often pose difficult diagnostic dilemmas. Electron microscopy continues to be a gold standard in the identification of mesothelial differentiation. However, it is very common to apply long panels of antibodies for that purpose. In most cases, light microscopy and immunohistochemistry will solve the problem. However, the definitive, specific, and sensitive immunohistochemical marker is still lacking. This is particularly true in peritoneal and testicular mesothelial tumors, in which common embryologic origin with epithelial elements results in overlapping immunohistochemistry and morphology. The particularities of peritoneal and testicular mesothelial proliferations, and the main tumors that may mimic them in these sites, as well as the value and limitations of immunohistochemistry and electron microscopy in their differential diagnosis are the subject of this review.


Subject(s)
Epithelium/pathology , Mesothelioma/diagnosis , Ovarian Neoplasms/diagnosis , Peritoneal Neoplasms/diagnosis , Testicular Neoplasms/diagnosis , Uterine Neoplasms/diagnosis , Biomarkers, Tumor/analysis , Cell Proliferation , Diagnosis, Differential , Epithelium/chemistry , Epithelium/ultrastructure , Female , Humans , Immunohistochemistry , Male , Mesothelioma/chemistry , Mesothelioma/ultrastructure , Microscopy, Electron, Transmission , Ovarian Neoplasms/chemistry , Ovarian Neoplasms/ultrastructure , Peritoneal Neoplasms/chemistry , Peritoneal Neoplasms/ultrastructure , Testicular Neoplasms/chemistry , Testicular Neoplasms/ultrastructure , Uterine Neoplasms/chemistry , Uterine Neoplasms/ultrastructure
18.
Am J Surg Pathol ; 30(1): 1-6, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16330935

ABSTRACT

Malignant mesotheliomas of the testis arise from the tunica vaginalis, formed from the evagination of the abdominal peritoneum into the scrotum. The immunohistochemical profile of the tunica vaginalis and associated neoplasms is often extrapolated from thoracic studies. Testicular series are uncommon, usually derived from previous case studies and literature reviews. The immunohistochemical findings in 20 cases originally diagnosed as malignant mesotheliomas are presented. Archival testicular malignant mesothelioma specimens from 1959 to 2004 were collected from hospitals throughout the United Kingdom and from the authors' own archives. Hematoxylin and eosin-stained sections were reviewed, and selected sections from each case were then examined using an immunohistochemical panel of eight antibodies: calretinin (Zymed, 1:200), epithelial membrane antigen (EMA) (DAKO, 1:50), thrombomodulin (DAKO 1:5), CK7 (DAKO, 1:100), CK5-CK6 (DAKO, 1:10), BerEp4 (DAKO, 1:25), carcinoembryonic antigen (CEA) (DAKO, 1:10), and CK20 (DAKO, 1:100). The EnVision technique was used for all antibodies. Sections were reviewed independently by three pathologists. Electron microscopy was performed on selected cases. In all cases, the morphologic light microscopy criteria for a diagnosis of malignant mesothelioma were present. However, two tumors were later excluded from the study because of diffuse strong positive immunostaining with CK20 and BerEp4 and an ultrastructural appearance of adenocarcinoma. Of the remaining cases, 15 of 18 (83%) were purely epithelioid in type, showing a mixture of papillary, tubular, and solid patterns, and 3 of 18 (17%) showed a mixed sarcomatoid/epithelioid pattern. All cases were positive for calretinin and EMA (100%), 16 of 18 (89%) were positive for thrombomodulin, and 15 of 18 (83%) were positive for CK7. CK5-CK6 positivity was present in 13 of 18 (72%) but varied in strength and distribution; 2 of 18 (11%) were positive for BerEp4. All the cases were negative for CK20 and CEA. Four of the 18 cases were examined by electron microscopy, which revealed long thin microvilli supporting a diagnosis of malignant mesothelioma. This study has shown that the immunocytochemical profile of testicular malignant mesotheliomas is similar to those arising in the pleura, with diffuse positivity for calretinin, EMA, thrombomodulin, and CK7, and negative for CK20 and CEA. Focal weak positivity may be encountered with BerEp4. However, histopathologists should be aware of the variability in CK5-6 staining in testicular specimens when compared with pleural mesotheliomas.


Subject(s)
Biomarkers, Tumor/analysis , Mesothelioma/metabolism , Mesothelioma/ultrastructure , Testicular Neoplasms/metabolism , Testicular Neoplasms/ultrastructure , Aged , Humans , Immunohistochemistry , Male , Microscopy, Electron, Transmission , Middle Aged , Retrospective Studies
19.
Neoplasia ; 8(12): 1019-27, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17217619

ABSTRACT

Carcinoma in situ (CIS) is the noninvasive precursor of most human testicular germ cell tumors. In normal seminiferous epithelium, specialized tight junctions between Sertoli cells constitute the major component of the blood-testis barrier. Sertoli cells associated with CIS exhibit impaired maturation status, but their functional significance remains unknown. The aim was to determine whether the blood-testis barrier is morphologically and/or functionally altered. We investigated the expression and distribution pattern of the tight junction proteins zonula occludens (ZO) 1 and 2 in normal seminiferous tubules compared to tubules showing CIS. In normal tubules, ZO-1 and ZO-2 immunostaining was observed at the blood-testis barrier region of adjacent Sertoli cells. Within CIS tubules, ZO-1 and ZO-2 immunoreactivity was reduced at the blood-testis barrier region, but spread to stain the Sertoli cell cytoplasm. Western blot analysis confirmed ZO-1 and ZO-2, and their respective mRNA were shown by RT-PCR. Additionally, we assessed the functional integrity of the blood-testis barrier by lanthanum tracer study. Lanthanum permeated tight junctions in CIS tubules, indicating disruption of the blood-testis barrier. In conclusion, Sertoli cells associated with CIS show an altered distribution of ZO-1 and ZO-2 and lose their blood-testis barrier function.


Subject(s)
Blood-Testis Barrier/metabolism , Carcinoma in Situ/metabolism , Membrane Proteins/biosynthesis , Phosphoproteins/biosynthesis , Sertoli Cells/metabolism , Testicular Neoplasms/metabolism , Adult , Blood-Testis Barrier/physiopathology , Blood-Testis Barrier/ultrastructure , Carcinoma in Situ/genetics , Carcinoma in Situ/ultrastructure , Gene Expression Regulation, Neoplastic/physiology , Humans , Male , Membrane Proteins/genetics , Middle Aged , Phosphoproteins/genetics , Sertoli Cells/ultrastructure , Testicular Neoplasms/genetics , Testicular Neoplasms/ultrastructure , Zonula Occludens-1 Protein , Zonula Occludens-2 Protein
20.
Stem Cell Rev ; 1(3): 273-6, 2005.
Article in English | MEDLINE | ID: mdl-17142865

ABSTRACT

In this article, a brief review of the research that began with the study of murine teratomas of the testis and ultimately led to the culture of human embryonic stem cells is discussed. Most of the space will be devoted to the studies in which the author personally took part, and the discussion will also touch upon some of the crucial experiments important for the understanding of this entire research effort.


Subject(s)
Embryonic Stem Cells/metabolism , Teratocarcinoma/metabolism , Teratoma/metabolism , Testicular Neoplasms/metabolism , Animals , Biomedical Research/trends , Cell Culture Techniques/methods , Embryonic Stem Cells/ultrastructure , Humans , Male , Mice , Teratocarcinoma/ultrastructure , Teratoma/ultrastructure , Testicular Neoplasms/ultrastructure , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL